✦ LIBER ✦

Signaling Mechanisms in Neuroendocrine Tumors as Targets for Therapy

✍ Scribed by Zarebczan, Barbara; Chen, Herbert

Book ID: 123084222
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 318 KB
Volume: 39
Category: Article
ISSN: 0889-8529
DOI: 10.1016/j.ecl.2010.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Signaling Mechanisms in Neuroendocrine T

Signaling Mechanisms in Neuroendocrine Tumors as Targets for Therapy

✍ Zarebczan, Barbara; Chen, Herbert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Neuroendocrine tumors (NETs) are rare, with an incidence of 2 to 5 per 100,000 people. These tumors secrete hormones such as 5-hydroxytryptamine (5-HT) (serotonin), chromogranin A (CgA), neuron-specific enolase (NSE), and synaptophysin. These hormones can cause debilitating symptoms of carcinoid syn

Molecular Targeted Therapy for Neuroendo

Molecular Targeted Therapy for Neuroendocrine Tumors

✍ Yao, James C.; Hoff, Paulo M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Integrins as signaling molecules and tar

Integrins as signaling molecules and targets for tumor therapy

✍ Ruoslahti, Erkki 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 463 KB

Targeting the mTOR Signaling Pathway in

Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors

✍ Jennifer Chan MD, MPH,Matthew Kulke MD, MMSc 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 550 KB

Sunitinib paves the way for targeted the

Sunitinib paves the way for targeted therapies in neuroendocrine tumors

✍ Eric Raymond; Sandrine Faivre; Pascal Hammel; Philippe Ruszniewski 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 59 KB

Signaling Pathways as Specific Pharmacol

Signaling Pathways as Specific Pharmacologic Targets for Neuroendocrine Tumor Therapy: RET, PI3K, MEK, Growth Factors, and Notch

✍ Carter, Yvette; Jaskula-Sztul, Renata; Chen, Herbert; Mazeh, Haggi 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 282 KB